Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

July 31, 2005

Conditions
Drug Toxicity
Interventions
DRUG

High Dose Soy isoflavones

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of North Carolina

OTHER

NCT00491595 - Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women | Biotech Hunter | Biotech Hunter